Chengda Pharmaceutical Co., Ltd
Initial public offering and listing on GEM
Announcement of online Winning Results
Sponsor (lead underwriter): Everbright Securities Company Limited(601788)
hot tip
The application of Chengda Pharmaceutical Co., Ltd. (hereinafter referred to as “Chengda pharmaceutical” or “the issuer”) for initial public offering of no more than 24174035 ordinary shares (A shares) (hereinafter referred to as “this offering”) has been examined and approved by the GEM Listing Committee of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”), It has been approved for registration by China Securities Regulatory Commission (zjxk [2021] No. 3857).
Investors are kindly requested to pay attention to the payment link of this offering and timely fulfill their payment obligations on January 12, 2022 (T + 2):
1. After winning the subscription of new shares, online investors shall fulfill the obligation of capital settlement in accordance with the announcement on the results of online winning the initial public offering of shares and listing on the gem of Chengda Pharmaceutical Co., Ltd., so as to ensure that their capital account will eventually have sufficient new share subscription funds on January 12 (T + 2) 2022, and the insufficient part shall be deemed as abandoning the subscription, The resulting consequences and relevant legal liabilities shall be borne by the investors themselves. The investor’s fund transfer shall comply with the relevant provisions of the securities company where the investor is located.
The shares abandoned by online investors shall be underwritten by the sponsor (lead underwriter) Everbright Securities Company Limited(601788) (hereinafter referred to as “sponsor (lead underwriter)”).
2. When the total number of shares paid and subscribed by offline and online investors is less than 70% of the number of public offerings after deducting the final strategic placement, the issuer and the sponsor (lead underwriter) will suspend the issuance of new shares and disclose the reasons for the suspension and subsequent arrangements.
3. If an online investor fails to pay in full after winning the lottery three times in a row within 12 months, it shall not participate in the online subscription of new shares, depositary receipts, convertible corporate bonds and exchangeable corporate bonds within 6 months (calculated as 180 natural days, including the next day) from the next day of the settlement participant’s latest declaration of abandoning the subscription.
4. Once this announcement is published, it shall be deemed to have served the notice of allocated payment to the online investors who have participated in the online subscription and won the lot.
According to the announcement of Chengda Pharmaceutical Co., Ltd. on initial public offering and listing on GEM, On the morning of January 11, 2022 (T + 1), the issuer and the sponsor (lead underwriter) presided over the signing ceremony of Chengda Pharmaceutical Co., Ltd. in its initial public offering and listing on the gem at Room 308, Shenye center, No. 5045, Shennan East Road, Luohu District, Shenzhen. The lottery ceremony was conducted and notarized under the supervision of the representative of Shenzhen Luohu notary office in accordance with the principles of openness, fairness and impartiality. The winning results are hereby announced as follows:
Last digit winning lot number
Last “4” digits: 4545
Last “5” digits: 55437754379543715437354378939039390
Last “6” digits: 200058
Last “7” digits: 3509943
Last “8” digits: 46347087713470879634708721347087
Last “9” digits: 066039638
If the mantissa of the subscription allotment number held by the investors participating in the online pricing issuance is the same as the above number, it is the winning number. There are 21635 winning numbers in total, and each winning number can only subscribe for 500 A-Shares of Chengda Pharmaceutical Co., Ltd.
Issuer: recommendation institution (lead underwriter) of Chengda Pharmaceutical Co., Ltd.: Everbright Securities Company Limited(601788) January 12, 2022 (there is no text on this page, which is the seal page of the announcement on the results of Chengda Pharmaceutical Co., Ltd. initial public offering of shares and listing on the gem online)
Issuer: Chengda Pharmaceutical Co., Ltd. (this page has no text and is the seal page of the announcement on the results of Chengda Pharmaceutical Co., Ltd. initial public offering of shares and online lottery on GEM Listing)
Sponsor (lead underwriter): Everbright Securities Company Limited(601788) mm / DD / yy
